Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034925.xml
Hamostaseologie 2005; 25(02): 205-208
DOI: 10.1055/s-0037-1619656
DOI: 10.1055/s-0037-1619656
Original Article
Leberzirrhose und Gerinnungsstörungen
Liver cirrhosis and coagulopathyFurther Information
Publication History
Publication Date:
27 December 2017 (online)
Zusammenfassung
Die Leberzirrhose ist häufig assoziiert mit komplexen Gerinnungsstörungen und einer Thrombozytopenie. Durch die verminderte Syntheseleistung tritt eine Vielzahl von Störungen auf, die eine sorgfältige Diagnose und gezielte Therapie auf der Intensivstation erfordern.
Summary
In patients with chronic liver disease profound coagulation changes and thrombocytopenia may lead to life-threatening bleeding that requires thorough diagnosis and immediate blood product replacement.
-
Literatur
- 1 Bernstein D. Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child’s B and C cirrhosis. Semin Thromb Hemost 2000; 26: 437-8.
- 2 Bizollon T. Fibrinolytic therapy for portal vein thrombosis. Lancet 1991; 337: 1416.
- 3 Bravo AA, Seth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500.
- 4 Carmassi F, Morale M, DeNegri F. et al. Modulation of hemostatic balance with antithrombin replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis. J Mol Med 1995; 73: 89-93.
- 5 Carr JM. Disseminated intravascular coagulation in cirrhosis. Hepatology 1989; 10: 103-10.
- 6 Chan V, Lai CL, Chan TK. Metabolism of antithrombin III in cirrhosis and cancer of the liver. Clin Sci 1981; 60: 681-8.
- 7 Child CG, Turcotte JG. Surgery and Portal Hypertension. Philadelphia: Saunders; 1964: 50-64.
- 8 Condat B, Pessione F, Hillaire S. et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001; 120: 490-7.
- 9 DeCaterina MI, Tarantino G, Farina C. Haemostasis unbalance in Pugh-scored liver cirrhosis; characteristic changes of plasma levels of protein C versus protein S. Haemostasis 1993; 23: 229-35.
- 10 Denninger MH, Chait Y, Casadevall N. et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587-91.
- 11 Francis JL, Armstrong DJ. Acquired dysfibrinogenaemia in liver disease. J Clin Pathol 1982; 35: 667-72.
- 12 Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood 1999; 93: 1798-808.
- 13 Green AJ, Ratnoff OD. Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF like antigen in alcoholic cirrhosis of the liver. J Lab Clin Med 1974; 83: 189-97.
- 14 Hu KQ, Yu AS, Tiyyagura L. et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 2001; 96: 1581-6.
- 15 Izumi S, Langley PG, Wendon J. et al. Coagulation factor V levels as a prognostic indicator or in fulminant hepatic failure. Hepatology 1996; 23: 1507-11.
- 16 Köhler M, Hellstern P, Lechler E. et al. Thromboembolic complications associated with the use of prothrombin complex an factor IX concentrates. Thromb Haemost 1998; 80: 395-402.
- 17 Mammen EF. Coagulopathies of liver disease. Clin lab Med 1994; 14: 769-80.
- 18 Mann O, Haag K, Hauenstein KH. et al. Septische Pfortaderthrombose. Dtsch Med Wochenschr 1995; 120: 1201-6.
- 19 Mannucci PM, Vicente V, Vianello L. Controlled trial of desmopressin in liver cirrhosis and other bleeding time. Blood 1986; 67: 1148.
- 20 Paramo JA, Rocha E. Hemostasis in advanced liver disease. Sem Thromb Hemost 1993; 19: 184-90.
- 21 Pugh RNH, Muray-Lyon IM, Dawson JL. et al. Transection of the esophagus in the bleeding esophageal varices. Br J Surg 1973; 60: 648-52.
- 22 Rapaport SI. Coagulation problems in liver disease. Blood Coagul Fibrinol 2000; 11: 69-74.
- 23 Scharrer I, Encke A, Hottenrott C. Clinical cure of haemophilia A by liver transplantation. Lancet 1988; I: 800-1.
- 24 Vigano S, Mannucci PM, D’Angelo A. et al. The significance of protein C antigen in acute and chronic liver biliary disease. Am J Clin Pathol 1985; 84: 454-8.
- 25 Violi F, Ferro D, Basili S. et al. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis. J Invest Med 1995a 43: 550-4.
- 26 Violi F, Ferro D, Basili S. et al. Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. Hepatology 1995b 22: 96-100.